OneFul, with a valuation of $9.8 million, is raising funds on NetCapital. It is a pharma tech company that has developed several innovative drug delivery products. OneFul uses its patented personalized and automated medicine formulation software to create combined treatments for multiple pharmaceuticals. The company’s flagship product is a cardiovascular polypill that combines 3-7 medicines into a single gel packet and delivers personalized combination treatment. Edison T Hudson founded OneFul in September 2013. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $536,500. The campaign proceeds will be used for company employment, marketing, inventory, product development, G&A, and working capital.